Building the Future of Diagnostics: AMA with CurieDX Founder Dr. Therese Canares
Join District Angels & Play Money for an investor AMA with Dr. Therese Canares, founder of CurieDX, an AI-powered diagnostics platform transforming how we diagnose common infections.
Big news: We've reopened our CurieDX investment with significantly improved terms - including a higher tax refund via Maryland's BIITC program and a better-aligned lead investor backing the round. Whether you're discovering this opportunity for the first time or have been tracking it for a while, this is your chance to hear directly from Therese and understand what's changed (and why it matters).
What to Expect
We've structured this AMA so everyone gets value, whether you're brand new to CurieDX or already familiar:
3:00-3:30 PM: CurieDX's mission, Therese's founder journey from the ER to building this platform, and the technology powering the solution
3:30-4:00 PM: Deep dive on traction updates, the improved deal terms, what changed with the lead investor, and BIITC mechanics
💡 Deal Highlight: CurieDX
Founder: Therese Canares: MD based, former Johns Hopkins pediatric ER doctor, building an AI diagnostics platform for Common Infections because traditional diagnostics tools are slow, expensive, and often inaccurate (64% industry standard)
Raising $1.5M at a $9M pre-money valuation (offering BIITC credit with 58% refund on investment as investor incentive)
⚙️ What Makes It Different
CurieDX platform analyzes 64M+ data points to screen common infections (strep, UTI, pink eye) with 90% accuracy from wherever you are
👍 Why We're Excited
Multi-disease scalable platform (5 patents filed)
Early pre-FDA revenue generation with urgent care partners with short sales cycles
$1.1M+ in non-dilutive funding (BARDA, NSF)
Positioned to expand from common to chronic conditions
Eligible for Maryland BIITC credit with 58% tax refund availability
Hosted by District Angels in partnership with Play Money!